This article has Open Peer Review reports available.
A 13-year old girl with pancytopenia at the presentation of a Borrelia hispanica infection: a case report and review of the literature
© The Author(s). 2017
Received: 19 July 2016
Accepted: 26 January 2017
Published: 27 February 2017
It is not uncommon that a child with a febrile illness of unknown etiology is admitted to the hospital. When the complete blood count reveals a pancytopenia, the diagnostic process can be a real challenge.
A 13-year girl of Arab-Berber descent presented with abdominal pain and fever after a holiday in northwestern Morocco. A complete blood count revealed a pancytopenia and blood smear test results revealed spirochetes. Borrelia hispanica was identified by sequencing the 16S ribosomal ribonucleic acid gene. Our patient was treated with tetracyclines and during this treatment we saw full clinical and hematological recovery.
Borrelia hispanica is a known cause of tick-borne relapsing fever and is transmitted to humans through the bite of soft ticks of the genus Ornithodoros (Alectorobius). Although the link between tick-borne relapsing fever and thrombocytopenia has been documented, there are only a few case reports of tick-borne relapsing fever presenting with pancytopenia. To the best of our knowledge, there is no previous report of Borrelia hispanica presenting with pancytopenia.
Climate change has increased migrant influx and increasing numbers of intercontinental travelers will cause higher prevalence of relatively unknown parasitic diseases in Western Europe. It is therefore not uncommon that a child with a febrile illness of unknown etiology is admitted to the hospital. The unfamiliarity of the pathology makes the diagnostic process a real challenge, especially when the presentation is unusual for an uncommon disease, like the one we present here.
A 13-year old girl of Arab-Berber descent (Morocco) presented to our emergency department because of abdominal cramps and pain in the right and left iliac fossa for 3 days, accompanied by vomiting and high fever. One week before, she had returned from a 2-month visit in northwestern Morocco. During her stay in Morocco, she was residing in the house of a family member. There was no contact with animals, no history of a tick bite, and she did not visit any parks or forests. She swam in the Mediterranean Sea and in a freshwater swimming pool, but she never went swimming in natural freshwater resources. She had not been sick during her stay and no skin rash was seen. Returning to Belgium, the next day she developed lower abdominal pain, diarrhea, vomiting, and high fever. After 4 days, she presented to the emergency department of our hospital.
Her medical history revealed a right-sided Bell’s palsy in the previous year with a magnetic resonance imaging (MRI) scan that showed a neuritis facialis, and a Borrelia serological test result that was negative. She had recurrent episodes of herpes labialis.
Spirochetes are Gram-negative bacteria with a double membrane and a helicoidal structure. Flagella are present, allowing the spirochete to rotate as it moves. They are divided into three families (Leptospiraceae, Brachyspiraceae and Spirochaetaceae) and are responsible for several diseases in humans, for example leptospirosis, Lyme disease, relapsing fever, syphilis and intestinal spirochaetosis. Tick-borne relapsing fever (TBRF) is an infection caused by spirochetes of the genus Borrelia, transmitted to humans through the bite of soft ticks (Ornithodoros species). It is caused by at least 16 distinct Borrelia species throughout the world [1, 2]. Borrelia species are Gram-negative helical bacteria that normally measure 0.2 to 0.5 μm in width and 5 to 20 μm in length. They are very hard to culture, but visible with dark-field and light microscopy. They have the corkscrew shape typical of all spirochetes . Each Borrelia species associated with relapsing fever appear to be specific to its tick vector .
First signs of TBRF are usually observed between 4 and 14 days after the tick bite, with an acute onset of high fever, headache, arthralgia, myalgia, neck stiffness, and abdominal complaints . Case fatality rate is 2–5% without treatment. Severity depends on Borrelia species, inoculum density, and underlying medical condition. Children and women appear to have a more intense course of disease . The primary episode usually lasts 3 days and is followed, after a fever-free interval of 7 days, by multiple other alternating episodes, often shorter and milder. During the febrile periods, numerous Borreliae are circulating in the blood and diagnosis can be made by observation of spirochetes on thin- or thick-blood smears with dark-field microscopy or with conventional microscopy after Giemsa, Wright or Diff-Quick staining [5, 6].
Borrelia cultures have not been widely used due to the low sensitivity range. Molecular methods are used with increasing frequency and offer the possibility of genus and even species identification . As such, Borrelia hispanica has been detected and isolated from specimens obtained in Northern Africa and Southern Europe, including Morocco, Spain, Portugal, Greece and Cyprus and is held responsible for 20.5% of patients with unexplained fever in northwestern Morocco [1, 8]. The disease caused by Borrelia hispanica is one of the less severe TBRFs, with neurological signs in less than 5% of cases . The preferred treatment for TBRF is tetracycline or doxycycline. When contraindicated, erythromycin is the alternative. In very sick patients (with neurologic symptoms) intravenous ceftriaxone can be added. No exact data is available in the literature about the association of TBRF and thrombocytopenia at presentation, but it is not uncommon . In contrast, TBRF presenting with pancytopenia is rare and only reported in a few case reports. Badger et al. described an infection with the recently discovered Borrelia miyamotoi and pancytopenia, and Chowdri et al. presented a case of a 59-year-old woman with borreliosis and pancytopenia. Her bone marrow was packed with Borrelia hermsii [3, 10]. Pancytopenia is a common manifestation of many tick-borne diseases; however the pathogenesis is poorly understood, possibly resulting from decreased bone marrow production, consumption due to widespread endothelial damage or due to immune-mediated destruction. Data on the prevalence of thrombocytopenia, neutropenia or anemia with Borrelia hispanica TBRF is not available and to the best of our knowledge, no reports of Borrelia hispanica presenting with pancytopenia have been published. Borrelia hispanica is transmitted through soft ticks, making co-infection of other tick-borne bacterial diseases like anaplasmosis or babesiosis, which are known to present with cytopenias, but transmitted through hard ticks of the Ixodes species, unlikely.
We report a case of a patient with Borrelia hispanica tick-borne relapsing fever presenting with abdominal pain, fever and pancytopenia. TBRF is a rare disease in Europe. It is found in some Mediterranean countries, and is a frequent cause of fever in northwestern Morocco. Therefore it should be in the differential diagnosis of travelers returning from these areas presenting with unexplained fever. Although the link between TBRF and thrombocytopenia has been documented, there are only a few cases of TBRF presenting with pancytopenia. To the best of our knowledge, this is the first report of Borrelia hispanica presenting with pancytopenia.
No funding was secured for this study.
Availability of data and materials
The data is noted in the report, additional information can be required from the corresponding author.
IL was responsible for the data collection, obtaining consent, and was the author of the manuscript. PB was responsible for providing one figure and part of the discussion section. BKM was responsible for part of the discussion and reviewing the manuscript. MO was responsible for carefully reviewing the manuscript. MA was responsible for obtaining consent, providing one figure, and for the writing and finalizing of the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patient’s legal guardian(s) for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
Ethics approval and consent to participate
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Rebaudet S, Parola P. Epidemiology of relapsing fever borreliosis in Europe. FEMS Immunol Med Microbiol. 2006;48:11–5.View ArticlePubMedGoogle Scholar
- Brouqui P, Bacellar F, Baranton G, Birtles RJ, Bjoersdorff A, Blanco JR, Caruso G, Cinco M, Fournier PE, Francavilla E, et al. Guidelines for the diagnosis of tick-borne bacterial diseases in Europe. Clin Microbiol Infect. 2004;10:1108–32.View ArticlePubMedGoogle Scholar
- Badger MS. Tick talk: unusually severe case of tick-borne relapsing fever with acute respiratory distress syndrome--case report and review of the literature. Wilderness Environ Med. 2008;19:280–6.View ArticlePubMedGoogle Scholar
- Dworkin MS, Schwan TG, Anderson Jr DE, Borchardt SM. Tick-borne relapsing fever. Infect Dis Clin North Am. 2008;22:449–68. viii.View ArticlePubMedPubMed CentralGoogle Scholar
- Barbour AG. Relapsing fever and other Borrelia infections. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases: principles, pathogens, and practice. Philadelphia: Churchill Livingstone; 1999.Google Scholar
- Johnson WD, Mandell GL. Borrelia species (relapsing fever). In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. New York: Churchill Livingstone; 2000.Google Scholar
- Brahim H, Perrier-Gros-Claude JD, Postic D, Baranton G, Jambou R. Identifying relapsing fever Borrelia, Senegal. Emerg Infect Dis. 2005;11:474–5.View ArticlePubMedPubMed CentralGoogle Scholar
- Sarih M, Garnier M, Boudebouch N, Bouattour A, Rihani A, Hassar M, Gern L, Postic D, Cornet M. Borrelia hispanica relapsing fever, Morocco. Emerg Infect Dis. 2009;15:1626–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Cadavid D, Barbour AG. Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis. 1998;26:151–64.View ArticlePubMedGoogle Scholar
- Chowdri HR, Gugliotta JL, Berardi VP, Goethert HK, Molloy PJ, Sterling SL, Telford SR. Borrelia miyamotoi infection presenting as human granulocytic anaplasmosis: a case report. Ann Intern Med. 2013;159:21–7.View ArticlePubMedGoogle Scholar